Real-World Survival Outcomes Associated With First-Line Immunotherapy, Targeted Therapy, and Combination Therapy for Metastatic Clear Cell Renal Cell Carcinoma-Reference-Cited by-同舟云学术

Real-World Survival Outcomes Associated With First-Line Immunotherapy, Targeted Therapy, and Combination Therapy for Metastatic Clear Cell Renal Cell Carcinoma

Published:2021-05-25 Issue:5 Volume:4 Page:e2111329
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Chakiryan Nicholas H.¹,Jiang Da David²,Gillis Kyle A.³,Green Elizabeth¹,Hajiran Ali¹,Hugar Lee¹,Zemp Logan¹,Zhang Jingsong¹,Jain Rohit K.¹,Chahoud Jad¹,Spiess Philippe E.¹,Sexton Wade¹,Gilbert Scott M.¹,Manley Brandon J.¹

Affiliation:

1. Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida

2. Department of Urology, Beth Israel Deaconess Medical Center, Boston, Massachusetts

3. Department of Urology, University of Iowa Hospitals & Clinics, Iowa City

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2780136/chakiryan_2021_oi_210331_1620833728.41479.pdf

Reference30 articles.

1. Cancer statistics, 2019.;Siegel;CA Cancer J Clin,2019

2. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease.;Janzen;Urol Clin North Am,2003

3. The impact of histological subtype on the incidence, timing, and patterns of recurrence in patients with renal cell carcinoma after surgery—results from RECUR Consortium.;Abu-Ghanem;Eur Urol Oncol

4. Renal cell carcinoma.;Cairns;Cancer Biomark,2010

5. Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma.;Motzer;N Engl J Med,2018

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Socioeconomic and Demographic Disparities in Immunotherapy Utilization for Advanced Kidney and Bladder Cancer;Urologic Oncology: Seminars and Original Investigations;2024-11

2. Impact of Targeted Systemic Therapy and Radiotherapy on Patients Undergoing Spine Surgery for Metastatic Renal Cell Carcinoma;International Journal of Spine Surgery;2024-06

3. RENO Study: Clinical characteristics, treatment patterns and survival results in patients with metastatic renal cell carcinoma in Northern Spain;Seminars in Oncology;2024-06

4. Real world, multicentre patterns of treatment and survival in metastatic renal cell carcinoma with the UK Renal Oncology Collaborative (UK ROC): Is it time to look favourably on first‐line immunotherapy containing combinations in all IMDC groups?;Cancer Medicine;2024-06

5. Pathogenic Roles for RNASET2 in Clear Cell Renal Cell Carcinoma;Laboratory Investigation;2024-05